7210 Wareham Drive, Tampa, FL 33647
Sept. 12, 2024 Noom is the latest weight loss company to start prescribing compounded versions of the obesity medication semaglutide. This follows similar moves by Hims, Ro, and other telehealth companies capitalizing on shortages of brand-name obesity drugs. Noom will sell the compounded GLP-1 drug starting at $149 a month, it says. The company, which […]
Noom Offers Compounded Weight Loss Drugs Read More »
June 11, 2024 Kroger Health’s The Little Clinic LLC is announcing a renewed approach to its weight management program, offering a holistic and personalized approach to professional medical support and education. When medically appropriate, patients will be able to explore medical treatment, including GLP-1s such as Wegovy, Zepabound and others as part of their weight
Kroger’s Little Clinics Adds GLP-1 Drugs To Its Weight Loss Program Read More »
April 13, 2024 Marketdata LLC (parent company of DietBusinessWatch) has just released new research, a report entitled: “The Telehealth Weight Loss Market”. The market for weight loss programs delivered via telehealth / telemedicine companies is worth $6.9 billion, and growing. Telehealth soared during the pandemic in 2020 as consumers stayed home and communicated with their
Telehealth Weight Loss Market Worth $6.9 Billion And Growing Read More »